The molecular basis of focal cyst formation in human autosomal dominant polycistic kidney disease type I (1996)
- Authors:
- Autor USP: ONUCHIC, LUIZ FERNANDO - FM
- Unidade: FM
- Assunto: NEFROLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Cell
- Volume/Número/Paginação/Ano: v. 87, n. 6, p. 979-987, december 1996
-
ABNT
QIAN, Feng et al. The molecular basis of focal cyst formation in human autosomal dominant polycistic kidney disease type I. Cell, v. 87, n. 6, p. 979-987, 1996Tradução . . Acesso em: 04 mar. 2026. -
APA
Qian, F., Waitnick, T. J., Onuchic, L. F., & Germino, G. G. (1996). The molecular basis of focal cyst formation in human autosomal dominant polycistic kidney disease type I. Cell, 87( 6), 979-987. -
NLM
Qian F, Waitnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycistic kidney disease type I. Cell. 1996 ; 87( 6): 979-987.[citado 2026 mar. 04 ] -
Vancouver
Qian F, Waitnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycistic kidney disease type I. Cell. 1996 ; 87( 6): 979-987.[citado 2026 mar. 04 ] - Doenças císticas e tumores renais
- Refinement of the autosomal recessive polycystic kidney disease (PKHD1) interval and exclusion of an EF hand-containing gene as a PKHD1 candidate gene
- Regulation of CFTR Expression and Arginine Vasopressin Activity Are Dependent on Polycystin-1 in Kidney-Derived Cells
- Expression of Polyductin, the PKHD1 gene product, in Normal, Dysgenetic and Neoplastic Liver
- Genomic structure and exclusion of two candidate genes for the PKHD1 locus and three new polymorphic markers within the critical interval
- Direct association of full-lenght PKD1 and PKD2 proteins in mammalian cells
- Genomic structure of the gene for the human P1 protein (MCM3) and its exclusion as a candidate for atosomal recessive polycystic kidney disease
- Giant renal angiomyolipoma following ovarian stimulation therapy
- Hematúria em histórico de doença renal familiar
- KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
